More Web Proxy on the site http://driver.im/

Immunotherapy Combinations in Patients with Small Cell Lung Cancers

J Thorac Oncol. 2019 Oct;14(10):e244-e245. doi: 10.1016/j.jtho.2019.05.021.

Authors

Yuanliang Yan¹, Xi Chen¹, Jie Wei¹, Zhicheng Gong¹, Zhijie Xu²

Affiliations

¹ Department of Pharmacy, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
² Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China. Electronic address: xzj1322007@csu.edu.cn.

PMID: 31558244
DOI: 10.1016/j.jtho.2019.05.021

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal
Humans
Immunotherapy
Lung Neoplasms*
Phthalazines
Piperazines
Small Cell Lung Carcinoma*

Substances

Antibodies, Monoclonal
Phthalazines
Piperazines
durvalumab
olaparib